Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Admission To A Novel Hospital Ward

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00563186Not ApplicableCompleted

Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

Showing all 1 trials

Research Network

Common Treatments

  • Admission To A Novel Hospital Ward1

Active Sponsors

  • Alberta Heritage Foundation for Medical Research1
  • Calgary Health Region1
  • Canadian Institutes of Health Research (CIHR)1
  • University of Calgary1

Top Investigators

Related Conditions

  • Clostridium Difficile Infection1
  • Nosocomial Infection1
  • Vancomycin Resistant Enterococci Infection1

Activity Timeline